Using aid to finance coronavirus vaccine research may violate OECD rules
NewsMarch 26, 2020
/ By: Ann Danaiya Usher
Donors have committed large amounts to a multi-billion-dollar aid-financed initiative to develop vaccines against coronavirus. The OECD says this vaccine would benefit rich countries as much as poor countries and it may not allow contributions to be reported as aid.
The rest of the content is only available for subscribers.